PWMA
STOK icon

Pension & Wealth Management Advisors’s Stoke Therapeutics STOK Stock Holding History

Pension & Wealth Management Advisors’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.78K Hold
85
– – ﹤0.01% 492
2026
Q1 		$2.77K Buy
+85
New +$2.79K ﹤0.01% 458

Other funds holding STOK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Pension & Wealth Management Advisors's STOK Position: Q2 2026 in Review

Pension & Wealth Management Advisors held its Stoke Therapeutics (STOK) position steady in Q2 2026 at 85 shares worth $2.78K. The position accounts for ﹤0.01% of the portfolio, ranked #492.

Pension & Wealth Management Advisors first reported a position in STOK in Q1 2026 and has held it in 2 quarters since. 179 funds tracked by Wall St. Rank hold STOK as of Q2 2026.

  • Pension & Wealth Management Advisors held 85 shares of Stoke Therapeutics worth $2.78K as of Q2 2026.
  • Pension & Wealth Management Advisors left its Stoke Therapeutics share count unchanged in Q2 2026.
  • Stoke Therapeutics made up ﹤0.01% of Pension & Wealth Management Advisors's portfolio in Q2 2026, its #492 holding.
  • Pension & Wealth Management Advisors first reported a position in Stoke Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 179 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q2 2026.

Based on Pension & Wealth Management Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.